The store will not work correctly when cookies are disabled.
3-(2-Methoxyphenyl)-4-((2-(methylthio)phenyhamino)-1H-pyrrole-2,5-dione
ID: ALA4878043
PubChem CID: 164625823
Max Phase: Preclinical
Molecular Formula: C18H16N2O3S
Molecular Weight: 340.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1C1=C(Nc2ccccc2SC)C(=O)NC1=O
Standard InChI: InChI=1S/C18H16N2O3S/c1-23-13-9-5-3-7-11(13)15-16(18(22)20-17(15)21)19-12-8-4-6-10-14(12)24-2/h3-10H,1-2H3,(H2,19,20,21,22)
Standard InChI Key: KLVNGQIHHATTKB-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
9.8960 -15.9879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7132 -15.9879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9676 -15.2112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3046 -14.7291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6459 -15.2112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4716 -16.6862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6523 -16.6664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2272 -17.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6204 -18.0837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4429 -18.0997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8642 -17.4005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1928 -16.6496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0061 -16.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4112 -17.3557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2238 -17.3557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6309 -16.6506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2196 -15.9441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4084 -15.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7452 -14.9598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8686 -14.9590 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0016 -18.0628 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.1844 -18.0616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2605 -15.9492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4435 -15.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
14 21 1 0
21 22 1 0
7 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.40 | Molecular Weight (Monoisotopic): 340.0882 | AlogP: 2.90 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.56 | CX Basic pKa: ┄ | CX LogP: 2.42 | CX LogD: 2.42 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.65 | Np Likeness Score: -0.41 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |